Abbott Diagnostics Analyzers: Complete Product Portfolio, Laboratory Systems & LabDecoded Review

From Alinity and ARCHITECT to chemistry, immunoassay, hematology, molecular diagnostics, point-of-care and blood screening — this guide examines Abbott's major diagnostic platforms from a practical laboratory perspective.

Alinity ARCHITECT Clinical Chemistry Immunoassay Hematology Molecular POC Automation

Abbott is not simply a chemistry or immunoassay analyzer manufacturer. It is one of the major global diagnostics companies with a portfolio spanning clinical chemistry, immunoassay, hematology, molecular diagnostics, point-of-care testing, diabetes diagnostics, blood screening, infectious disease testing and laboratory workflow solutions.

For laboratories evaluating Abbott, the important question is therefore not simply “Which Abbott analyzer should we buy?” The more useful question is:

“Which Abbott platform architecture best fits our workload, assay mix, laboratory workflow, staffing model, space, service environment and five-year total cost of ownership?”

That distinction matters because Abbott's portfolio includes the modern Alinity family, established ARCHITECT platforms and specialized systems covering hematology, molecular diagnostics, point-of-care testing and blood screening.

Why this Abbott guide is different: LabDecoded evaluates laboratory systems from the perspective of the working laboratory — not just advertised throughput. The assessment focuses on effective throughput, assay menu, reagent economics, calibration, QC, sample handling, STAT workflow, automation, downtime, serviceability, LIS connectivity, footprint and cost per reportable result.

What This Abbott Analyzer Guide Covers

This article is designed as the Abbott Diagnostics portfolio hub for LabDecoded. Instead of reviewing only one chemistry or immunoassay analyzer, it maps the major Abbott laboratory product lines and explains where each platform fits within a modern diagnostic laboratory.

Abbott Product Area	Major Platforms / Families	Typical Laboratory Application
Clinical Chemistry	Alinity c, ARCHITECT c	Routine and specialized chemistry
Immunoassay	Alinity i, ARCHITECT i	Hormones, tumor markers, infectious disease and specialty immunoassays
Integrated Core Laboratory	Alinity ci	Combined chemistry + immunoassay workflow
Hematology	Alinity h, CELL-DYN family	CBC and differential testing
Diabetes Diagnostics	HbA1c and glucose testing solutions	Diabetes diagnosis and monitoring
Molecular Diagnostics	Alinity m and related molecular platforms	Automated molecular testing
Point of Care	i-STAT, Afinion and related solutions	Near-patient testing
Blood Screening	Alinity s and related solutions	Donor and blood screening
Automation	Core laboratory automation solutions	Sample handling and workflow optimization

Throughout this guide, Alinity and ARCHITECT should not be treated as interchangeable product generations. Laboratories replacing an existing Abbott system need to consider differences in workflow, reagent strategy, assay availability, automation, service requirements and total cost of ownership rather than simply choosing the newest model.

Important: Abbott product availability, analyzer configurations, assay menus, specifications, regulatory approvals and commercial positioning can differ by country and may change over time. Always confirm the exact configuration and current local documentation before procurement.

1. Abbott Diagnostics: A Broad Laboratory Portfolio

Abbott is unusual in the diagnostics market because its laboratory business extends well beyond the conventional chemistry-immunoassay core laboratory.

Depending on the laboratory segment, Abbott can participate in:

Clinical chemistry
Immunoassay
Integrated chemistry and immunoassay
Hematology
Diabetes diagnostics
Molecular diagnostics
Infectious disease testing
Point-of-care testing
Blood screening
Transfusion medicine
Cardiac testing
Automation
Laboratory informatics

This breadth is important for hospital networks and diagnostic chains that want to standardize multiple testing disciplines around a common manufacturer ecosystem.

2. Major Abbott Laboratory Product Lines

Laboratory Area	Major Abbott Families / Examples	Typical Role
Clinical Chemistry	Alinity c, ARCHITECT c	Routine and specialized chemistry
Immunoassay	Alinity i, ARCHITECT i	Hormones, tumor markers, infectious disease and specialty immunoassays
Integrated Core Lab	Alinity ci	Combined chemistry and immunoassay
Hematology	Alinity h, CELL-DYN family	CBC and differential testing
Diabetes	HbA1c and glucose solutions	Diabetes diagnosis and monitoring
Molecular	Alinity m and molecular platforms	Molecular diagnostics
Point of Care	i-STAT, Afinion and related solutions	Near-patient testing
Blood Screening	Alinity s and related solutions	Donor screening
Automation	Laboratory workflow solutions	Sample handling and core-lab automation

3. The Alinity Platform

Alinity is one of the most important modern Abbott laboratory platform families.

Rather than treating chemistry, immunoassay, hematology and molecular diagnostics as completely independent systems, Abbott has developed multiple Alinity platforms designed around standardized workflows, automation, connectivity and laboratory productivity.

Major Alinity laboratory systems

Alinity Platform	Primary Discipline	Typical Role
Alinity c	Clinical chemistry	Core chemistry
Alinity i	Immunoassay	Core immunoassay
Alinity ci	Chemistry + immunoassay	Integrated core laboratory
Alinity h	Hematology	CBC/differential workflow
Alinity m	Molecular diagnostics	Molecular testing
Alinity s	Blood screening	Donor screening applications

LabDecoded insight: Alinity should be viewed as a family of platforms rather than one analyzer. This is important when evaluating Abbott for a multi-department laboratory or diagnostic network.

4. Abbott Clinical Chemistry Systems

Alinity c

Abbott Alinity c

Category: Clinical chemistry

Role: Modern Abbott chemistry platform for routine and specialized chemistry testing.

Best suited for: Laboratories looking for a modern chemistry platform that can be integrated with immunoassay and broader laboratory workflow.

Alinity c is one of the most important Abbott systems for laboratories evaluating a replacement for an older chemistry platform.

Typical evaluation areas include:

Throughput under actual assay mix
Photometric chemistry performance
ISE availability and configuration
Reagent loading
Onboard reagent stability
Calibration requirements
QC management
Sample volume and dead volume
Repeat and dilution workflow
STAT capability
Automation connectivity
Service and uptime

ARCHITECT c

The ARCHITECT c family represents an established Abbott chemistry platform and remains important when evaluating existing Abbott installations, laboratory replacement cycles and transition to Alinity.

Abbott chemistry strategy

The key procurement question is not simply whether Alinity c is newer than ARCHITECT c. The more useful question is whether the proposed platform delivers better:

Productivity
Reagent economics
Footprint efficiency
Automation
Serviceability
Assay availability
Cost per reportable result

5. Abbott Immunoassay Systems

Alinity i

Abbott Alinity i

Category: Immunoassay

Applications: Endocrinology, fertility, oncology, infectious disease, cardiac and other immunoassay testing depending on local menu.

Laboratory role: Modern Abbott core immunoassay platform.

For a diagnostic laboratory, immunoassay evaluation should go far beyond headline throughput.

Important immunoassay evaluation criteria

Assay menu
Analytical sensitivity
Functional sensitivity where applicable
Measuring range
Interference characteristics
Calibration frequency
Reagent stability
Lot-to-lot management
Sample volume
STAT testing
Repeat/dilution capability
QC performance
Automation

ARCHITECT i

The ARCHITECT i family is an established Abbott immunoassay platform with a broad installed base. Laboratories transitioning from ARCHITECT to Alinity should compare not only analytical performance but also workflow, reagent logistics, service support and assay availability.

6. Alinity ci: Integrated Chemistry + Immunoassay

One of Abbott's important propositions for the core laboratory is the integration of chemistry and immunoassay.

Alinity ci

Combines: Clinical chemistry + immunoassay

Target environment: Hospital laboratories, diagnostic laboratories and core laboratories requiring integrated workflow.

Integrated systems can reduce manual sample transfer between departments and provide opportunities for consolidated staffing, sample routing and result management.

Evaluation Area	Integrated Approach	Separate Systems
Sample handling	Potentially consolidated	Separate workflows
Footprint	Potentially optimized	Usually greater
Staffing	Potentially consolidated	More department-specific
STAT management	Integrated workflow possible	Depends on individual analyzers
Automation	Designed for integrated workflow	Requires additional integration
Future scalability	Configuration dependent	Independent scaling

Important: Integration does not automatically mean better performance. A laboratory should compare actual workflow, analyzer redundancy, downtime strategy and sample routing before selecting an integrated platform.

7. Abbott Hematology

Abbott has a long history in hematology through the CELL-DYN family and newer Alinity h solutions.

Alinity h

The Alinity h family represents Abbott's modern hematology strategy, designed around automation, productivity and integration.

CELL-DYN

CELL-DYN is an established Abbott hematology family with numerous installed systems worldwide.

Family	Laboratory Role	Key Evaluation Parameters
Alinity h	Modern hematology	CBC, differential, flags, automation, workflow
CELL-DYN family	Established hematology	Performance, installed base, service, replacement strategy

What should a laboratory evaluate?

5-part differential
NRBC capability
Platelet performance
Flagging efficiency
Abnormal cell detection
Smear review rate
Carryover
Sample volume
Throughput
Reagent consumption
Automation
Digital morphology connectivity

8. Abbott Diabetes Diagnostics

Diabetes testing is a major diagnostic category where Abbott has a particularly broad presence.

For laboratory professionals, the important distinction is between:

Central-laboratory HbA1c testing
Point-of-care HbA1c testing
Glucose testing
Continuous glucose monitoring

Abbott's diabetes portfolio extends beyond conventional central-laboratory analyzers into point-of-care and glucose-monitoring technologies.

HbA1c laboratory evaluation

For HbA1c platforms, LabDecoded recommends evaluating:

Measurement principle
Variant detection
HbF influence
Hemoglobinopathy interference
Carbamylated Hb interference
NGSP certification
IFCC traceability
Calibration
QC stability
Sample type
Throughput
Cost per test

LabDecoded HbA1c principle: A high HbA1c throughput does not automatically mean a superior HbA1c platform. Laboratories must understand the measurement technology and its behavior with hemoglobin variants and other analytical challenges.

9. Abbott Molecular Diagnostics

Alinity m

Abbott Alinity m

Category: Molecular diagnostics

Laboratory role: Automated molecular diagnostics and infectious-disease testing, depending on locally available assays.

Molecular diagnostics represents a fundamentally different procurement decision from chemistry or immunoassay.

Key evaluation parameters

Sample-to-result workflow
Extraction efficiency
Amplification technology
Multiplex capability
Internal controls
Contamination control
Throughput
Batch size
Random access
Reagent stability
Assay menu
Open versus closed system
Turnaround time
LIS integration

Where Abbott molecular systems can be attractive

Hospital molecular laboratories
Infectious disease testing
High-throughput diagnostic laboratories
Centralized molecular testing
Laboratories seeking integrated Abbott workflow

Do not compare molecular systems using PCR cycle time alone. Sample preparation, hands-on time, invalid rate, repeat testing, reagent utilization, contamination management and total cost per reportable result are equally important.

10. Abbott Point-of-Care Diagnostics

Abbott has one of the strongest point-of-care portfolios among major diagnostics companies.

i-STAT

The i-STAT platform is widely associated with near-patient blood testing, particularly in emergency and critical-care environments.

Depending on cartridge and market, testing may include combinations of blood gases, electrolytes, metabolites and selected cardiac or other analytes.

Afinion

The Afinion family provides near-patient testing solutions including HbA1c and other assays depending on the platform and local menu.

POC evaluation

A POC analyzer should be evaluated differently from a central-laboratory analyzer.

Ease of operation
Operator training
QC lockouts
Patient identification
Connectivity
Result security
Cartridge stability
Waste management
Cost per reportable result
Remote monitoring

11. Abbott Infectious Disease Diagnostics

Abbott participates in infectious disease diagnostics through both immunoassay and molecular technologies.

Approach	Typical Application
Immunoassay	Antigen/antibody-based testing
Molecular	Pathogen nucleic acid detection
Point-of-care	Rapid near-patient testing
Blood screening	Donor infectious disease screening

For laboratory procurement, assay sensitivity and specificity should be evaluated together with prevalence, clinical application, confirmatory workflow and local regulatory requirements.

12. Blood Screening and Transfusion Diagnostics

Abbott also has a major presence in blood screening and transfusion-related diagnostics.

Alinity s

The Alinity s platform is part of Abbott's blood screening portfolio.

Blood-screening laboratories have very different requirements from routine diagnostic laboratories, including:

Very high specimen volumes
Traceability
Donor/sample identification
Regulatory compliance
High system uptime
Batch management
Quality assurance
Redundancy
Result security
Instrument-to-information-system connectivity

13. Abbott Automation and Laboratory Workflow

Automation should not be considered an optional accessory in a high-volume laboratory. At sufficient scale, it becomes a core component of laboratory productivity.

Areas where automation can create value

Sample reception
Barcode identification
Centrifugation
Decapping
Sorting
Aliquoting
Analyzer routing
Repeat testing
Reflex testing
Sample storage
Sample retrieval

When evaluating Abbott automation, the laboratory should calculate how many manual touches are removed per sample.

LabDecoded metric: Count manual touches per 1,000 samples. This can be more informative than simply comparing analyzer throughput.

14. Laboratory Informatics and Connectivity

A modern analyzer is only one component of a laboratory information ecosystem.

Abbott systems should be evaluated for connectivity with:

LIS
Middleware
Hospital information systems
POC management systems
Quality-control systems
Remote monitoring
Auto-verification
Analyzer-to-analyzer workflows

Questions for the IT team

Can the analyzer communicate bi-directionally with the LIS?
Can auto-verification rules be implemented?
Can delta checks be automated?
Can critical values be handled electronically?
Can QC status influence result release?
Can multiple laboratories be monitored centrally?
How are analyzer downtime events handled?

15. Major Abbott Product-Line Comparison

Abbott Product Family	Representative Platform	Discipline	Typical Laboratory Position
Alinity c	Alinity c	Clinical chemistry	Modern core laboratory chemistry
Alinity i	Alinity i	Immunoassay	Core immunoassay
Alinity ci	Alinity ci	Chemistry + immunoassay	Integrated core laboratory
ARCHITECT c	ARCHITECT chemistry	Chemistry	Established Abbott installation
ARCHITECT i	ARCHITECT immunoassay	Immunoassay	Established high-volume immunoassay
Alinity h	Alinity hematology	Hematology	Modern hematology workflow
CELL-DYN	CELL-DYN family	Hematology	Established hematology laboratories
Alinity m	Alinity m	Molecular	Automated molecular diagnostics
Alinity s	Alinity s	Blood screening	Donor screening
i-STAT	i-STAT family	POC	Emergency / critical care / near-patient testing
Afinion	Afinion family	POC	Near-patient testing

16. The Abbott Laboratory Ecosystem

A major advantage of a broad manufacturer portfolio is the possibility of standardization across different departments.

Laboratory Function	Potential Abbott Solution
Core chemistry	Alinity c
Core immunoassay	Alinity i
Integrated core lab	Alinity ci
Hematology	Alinity h / CELL-DYN family
HbA1c / diabetes testing	Alinity-related / POC solutions
Molecular	Alinity m
Blood screening	Alinity s
POC	i-STAT / Afinion
Infectious disease	Immunoassay + molecular platforms
LIS connectivity	Instrument/middleware integration

17. Which Abbott System Fits Which Laboratory?

Small Diagnostic Laboratory

Priorities usually include:

Compact footprint
Low maintenance
Reasonable reagent economics
Simple operation
Broad enough menu
Reliable service
LIS connectivity

A fully automated integrated system may not be necessary if sample volume is low.

Medium-Sized Laboratory

At this level, integrated chemistry and immunoassay becomes increasingly attractive.

The laboratory should model:

Daily samples
Peak hourly samples
Chemistry/immunoassay ratio
STAT workload
Repeat rate
Manual aliquoting
Staffing

Large Central Laboratory

A large laboratory should evaluate Abbott as a complete ecosystem rather than buying each analyzer independently.

Key considerations include:

Multiple analyzer redundancy
Automation
Sample routing
Core chemistry
Immunoassay
Hematology
Molecular testing
POC network management
LIS/middleware
Remote monitoring

Hospital Laboratory

Hospital laboratories should additionally prioritize STAT access, emergency testing, pediatric samples, critical-care diagnostics and downtime procedures.

18. Major Strengths of Abbott Diagnostics

1. Broad diagnostics ecosystem

Abbott can address multiple laboratory disciplines, from chemistry and immunoassay to hematology, molecular diagnostics and POC.

2. Alinity architecture

Alinity provides a modern platform strategy across multiple laboratory disciplines.

3. Strong immunoassay presence

Abbott has a long history in immunoassay through ARCHITECT and the newer Alinity i platform.

4. Strong point-of-care portfolio

i-STAT and other Abbott POC solutions provide a major advantage for hospital and near-patient diagnostics.

5. Molecular diagnostics

The Alinity m platform provides Abbott with an important position in automated molecular testing.

6. Diabetes diagnostics

Abbott's diabetes-related diagnostics and glucose technologies provide a broader ecosystem than a conventional central-lab manufacturer.

19. Limitations and Procurement Considerations

1. Portfolio complexity

A large portfolio can make product selection complicated.

2. Menu availability

The exact assay menu must always be checked for the country and intended application.

3. Service quality matters

The same analyzer can produce very different laboratory experiences depending on local field-service capability.

4. Legacy versus new-generation platforms

Laboratories with ARCHITECT or CELL-DYN systems should carefully assess whether they should continue, upgrade or migrate to newer Alinity platforms.

5. Total cost rather than instrument price

Reagent contracts, calibrators, controls, consumables, service and downtime can have a much larger long-term financial impact than the initial analyzer quotation.

20. Total Cost of Ownership

LabDecoded TCO formula:
Instrument + Reagents + Calibrators + QC + Consumables + Service + Labor + Downtime + IT + Automation + Utilities + Waste + Replacement Cost

Cost per reportable result

Laboratories should calculate:

Total annual operating cost ÷ total valid reportable results

and not merely:

Reagent pack price ÷ number of tests printed on the pack.

The difference can be substantial when calibration, QC, repeats, dead volume, wastage and downtime are included.

21. Abbott vs Siemens vs Roche vs Beckman Coulter vs QuidelOrtho

Manufacturer	Major Strength	Core-Lab Strategy	Key Comparison Point
Abbott	Broad diagnostics + Alinity ecosystem + POC	Alinity	Integration, menu, POC, TCO
Siemens Healthineers	Broad multidisciplinary ecosystem + automation	Atellica / Aptio	Automation, integration, service
Roche Diagnostics	Strong chemistry/immunoassay ecosystem	cobas	Menu, reagent economics, automation
Beckman Coulter	High-volume chemistry and automation	AU / DxC / automation	Throughput, uptime, automation
QuidelOrtho	VITROS dry-slide and integrated diagnostics	VITROS	Technology, workflow, service

There is no universal winner. The best system is the one that matches the laboratory's volume, assay mix, space, staffing, service environment and financial model.

22. Questions to Ask Abbott Before Purchase

Analytical

What is the exact assay menu available locally?
Which assays require separate calibrations?
What are the calibration intervals?
What is the reagent onboard stability?
What is the sample dead volume?
How are reruns and dilutions handled?
What interference studies are available?

Operational

What is the effective throughput with our actual assay mix?
How does the system perform during peak workload?
How are STAT samples handled?
What are daily and weekly maintenance requirements?
What are the most common service calls?
What is the average local response time?

Financial

What is the reagent cost per reportable result?
What annual reagent commitment is required?
What is included in the service contract?
Are spare parts included?
What uptime commitment is offered?
What happens during prolonged downtime?

IT and automation

Which LIS interfaces are supported?
Can third-party analyzers be integrated?
Is auto-verification supported?
Can QC information be integrated into result release?
Can multiple laboratories be monitored centrally?
What happens to sample routing when one analyzer goes offline?

23. LabDecoded Abbott Portfolio Scorecard

LabDecoded Assessment

Portfolio breadth: 9.5/10

Core laboratory capability: 9/10

Alinity ecosystem: 9/10

Immunoassay: 9.5/10

Point-of-care: 9.5/10

Molecular diagnostics: 9/10

Hematology: 8.5/10

Automation potential: 9/10

Scalability: 9/10

Small-laboratory simplicity: 8/10

High-volume laboratory suitability: 9/10

Overall LabDecoded assessment: 9.1/10

LabDecoded scores are editorial assessments designed to help laboratories structure their evaluation. They are not manufacturer ratings or clinical-performance claims.

24. Frequently Asked Questions

Is Abbott mainly a chemistry analyzer manufacturer?

No. Abbott has a broad diagnostics portfolio spanning chemistry, immunoassay, hematology, molecular diagnostics, point-of-care testing, blood screening and other diagnostic areas.

What is Abbott's major modern laboratory platform?

Alinity is one of Abbott's major modern platform families and includes chemistry, immunoassay, hematology, molecular and blood-screening solutions.

What is Alinity c?

Alinity c is Abbott's clinical chemistry platform for routine and specialized chemistry testing.

What is Alinity i?

Alinity i is Abbott's immunoassay platform used for a broad range of immunoassay applications depending on the local assay menu.

What is Alinity ci?

Alinity ci combines clinical chemistry and immunoassay within an integrated laboratory platform.

Does Abbott have hematology analyzers?

Yes. Abbott has the Alinity h family as well as the established CELL-DYN portfolio.

Does Abbott have molecular analyzers?

Yes. Alinity m is Abbott's major modern automated molecular diagnostics platform, with assay availability dependent on market.

Does Abbott have point-of-care testing?

Yes. Abbott has a major POC portfolio including i-STAT and Afinion-related solutions.

Is Abbott Alinity better than Siemens Atellica?

Neither is universally better. The appropriate choice depends on assay menu, workflow, throughput, footprint, service, automation, reagent economics and total cost of ownership.

Is Abbott better than Roche or Beckman Coulter?

Not universally. Abbott has particular strengths in integrated diagnostics, immunoassay, point-of-care and its broad Alinity ecosystem. The final decision should be based on the laboratory's actual requirements.

25. Final LabDecoded Verdict

Abbott should be evaluated as a complete diagnostics ecosystem, with Alinity at the center of its modern laboratory strategy.

The major strength of Abbott is not one individual analyzer. It is the breadth of the ecosystem across chemistry, immunoassay, hematology, molecular diagnostics, point-of-care, blood screening and diabetes diagnostics.

For a diagnostic chain, this breadth can provide opportunities for standardization across multiple laboratory sites and disciplines.

For a high-volume core laboratory, the key question is whether the proposed Alinity configuration delivers the required combination of:

High effective throughput
Low manual intervention
Reliable uptime
Broad assay menu
Efficient reagent utilization
Good STAT performance
Strong LIS connectivity
Scalable automation
Competitive cost per reportable result

The right question is therefore not:

“Is Abbott Alinity a good analyzer?”

It is:

“Does the proposed Abbott architecture provide the most efficient, reliable and scalable laboratory workflow for our specific workload?”

LabDecoded Procurement Checklist

Measure actual hourly workload.
Map chemistry and immunoassay sample overlap.
Calculate STAT percentage.
Review the complete assay menu.
Calculate reagent cost per reportable result.
Calculate QC and calibration costs.
Measure manual touches.
Assess automation possibilities.
Evaluate service response time.
Build a downtime strategy.
Evaluate LIS and middleware.
Calculate five-year TCO.
Compare the exact configuration against Siemens, Roche, Beckman Coulter and QuidelOrtho.

LabDecoded Abbott Analyzer Review Series

This article serves as the Abbott portfolio hub. Individual LabDecoded articles can subsequently link from here:

Replace these placeholder URLs with the final LabDecoded post URLs after the individual articles are published.

LabDecoded Editorial Note: Abbott product names, configurations, assay menus, specifications and regulatory status may vary by country and may change as product generations evolve. This article is intended as a laboratory technology and procurement guide and should be supplemented with current manufacturer documentation, product-specific IFUs and local regulatory information before purchase.

abbott-laboratory-systems